Correlation Between Dyadic International and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Indaptus Therapeutics, you can compare the effects of market volatilities on Dyadic International and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Indaptus Therapeutics.
Diversification Opportunities for Dyadic International and Indaptus Therapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dyadic and Indaptus is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and Indaptus Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to generate 0.88 times more return on investment than Indaptus Therapeutics. However, Dyadic International is 1.14 times less risky than Indaptus Therapeutics. It trades about -0.09 of its potential returns per unit of risk. Indaptus Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 178.00 in Dyadic International on December 28, 2024 and sell it today you would lose (41.00) from holding Dyadic International or give up 23.03% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dyadic International vs. Indaptus Therapeutics
Performance |
Timeline |
Dyadic International |
Indaptus Therapeutics |
Dyadic International and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Indaptus Therapeutics
The main advantage of trading using opposite Dyadic International and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |